Safety and Tolerability of ARD-3150, Inhaled Liposomal Ciprofloxacin, in Patients with Bronchiectasis and Chronic Pseudomonas Aeruginosa Infection: Results from Two Phase 3 Trials

S. Sethi,C. Haworth,A. M. Davis, I. Gonda, J. K. Froehlich,A. E. O'Donnell

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2018)

引用 3|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要